Medtrade Biopolymers

Medtrade Biopolymers is a leading medical device company specializing in the development of advanced wound care and hemostatic products. The company is best known for its proprietary chitosan-based technology, marketed under the brand Celox, which is used globally by military, emergency services, and surgical professionals to control life-threatening bleeding. Celox products are unique in their ability to clot blood independently of the body's natural clotting cascade, making them effective even in the presence of anticoagulants. Beyond hemostasis, Medtrade develops a range of innovative biopolymer solutions for chronic wound management, infection control, and surgical applications. In May 2024, the company was acquired by Advanced Medical Solutions Group (AMS) to integrate its high-margin hemostatic portfolio into a global distribution network.